Clinical Trials Data Microdosing 
The Cannigma
MARCH 7, 2021
People may not have to microdose psychedelics to feel their wellbeing benefits, according to a new study – they just have to believe they’ve microdosed them. Published in eLife , the new study found that participants who took placebos often reported the same beneficial effects as those that actually microdosed psychedelic substances.
Cannabis Law Report
JULY 25, 2022
million ($650,000) in funding from New Zealand’s Health Research Council (HRC) to conduct a LSD microdosing trial in patients with Major Depressive Disorder (MDD). The state agency grant funding followed the successful completion of a phase 1 clinical trial in 80 healthy participants.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
DECEMBER 2, 2021
(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.
Cannabis Law Report
JULY 9, 2022
Desperate to find any solution, she tried microdosing psilocybin mushrooms after researching the practice online. For Thornton, however, microdosing psilocybin mushrooms was a question of life or death. “I I decided to try microdosing psilocybin for depression because nothing else was working for me,” explains Thornton. “I
Cannabis Law Report
JUNE 19, 2022
For example, compounds such as psilocybin, mescaline, ibogaine, and LSD are being evaluated in clinical trials, but the compounds themselves are unpatentable because their existence is well documented in the prior art. Originally Published At Microdose. However, that does not mean that the path to patents is closed off.
Cannabis Law Report
FEBRUARY 9, 2022
But this is the first time Oregonians have been allowed to see some of the nuts and bolts of what some predict could grow into a billion-dollar industry nationally, according to Data Bridge Market Research. For example, there’s a desire among some people to microdose psilocybin, that is taking very small amounts every few days.
CannaMD
OCTOBER 7, 2019
In 2011, researchers published cross-sectional data from two population-based surveys including over 50,000 respondents. Are cannabis users really more likely to have better weight-to-height ratios than non-users? Believe it or not, science says: YES. Take the American Journal of Epidemiology.
Expert insights. Personalized for you.
124 
Let's personalize your content